INDIANAPOLIS, March 5, 2024 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting Nectin-4, KRAS G12D, and BRM (SMARCA2) will be presented at the American Association for Cancer Research (AACR) Annual Meeting, taking place April 5-10…
Month: March 2024
NEW YORK, March 5, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Archer-Daniels-Midland Company (NYSE: ADM) between April 30, 2020 and January 22, 2024, both dates inclusive (the “Class Period”), of the important March…
NEW YORK, March 5, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Archer-Daniels-Midland Company (NYSE: ADM) between April 30, 2020 and January 22, 2024, both dates inclusive (the “Class Period”), of the important March…
MORRISTOWN, N.J., March 5, 2024 /PRNewswire/ — BCN, a U.S.-based communications technology solution provider focused on multi-location businesses announces the appointment of Tom Boggs as Vice President of Service Delivery, effective March 1st. Tom Boggs joins BCN with over 20 years of…
MORRISTOWN, N.J., March 5, 2024 /PRNewswire/ — BCN, a U.S.-based communications technology solution provider focused on multi-location businesses announces the appointment of Tom Boggs as Vice President of Service Delivery, effective March 1st. Tom Boggs joins BCN with over 20 years of…
SINGAPORE, March 5, 2024 /PRNewswire/ — OKX, a leading Web3 technology company, has issued updates for March 6, 2024. OKX DEX API Integrated by Port3 Network, a Leading Decentralized AI Data Network Built for Web3 Port3 Network, a leading decentralized AI data network built for Web3, has…
The partnership aims to cultivate a new generation of deep tech companies emanating from McMaster’s academic entrepreneurs and will utilize Celesta Capital to accelerate commercialization SAN FRANCISCO, March 5, 2024 /PRNewswire/ — McMaster University and Celesta Capital today announced…
HAMILTON, ON and BOSTON, March 5, 2024 /PRNewswire/ — Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines, today announced that interim efficacy and safety data from the Phase 2…
Achieves 2023 Increased Outlook and Affirms 2024 Outlook HOUSTON, March 5, 2024 /PRNewswire/ — Total revenues of $337.9 million in Q4 2023 compared to $338.1 million in Q3 2023 Net loss of $7.9 million, or $0.28 per diluted share, in Q4 2023 compared to net income of $4.3 million, or…
Bechtel’s $7 million dollar commitment to the American Foundation for Suicide Prevention will provide critical resources and programming to 500,000 U.S. construction workers over the next five years. WASHINGTON, March 5, 2024 /PRNewswire/ — Bechtel and the American Foundation for Suicide…